AtlasClear Holdings, Inc. filed a Form 8-K on November 12, 2026, disclosing that NYSE American suspended trading of its common stock on November 10, 2026, and commenced proceedings to delist the company due to the low selling price of its shares.
Key Highlights
- Trading suspended: NYSE American suspended trading of AtlasClear Holdings common stock effective November 10, 2026.
- Delisting proceedings commenced: NYSE Regulation determined the company is "no longer suitable for listing" under Section 1003(f)(v) of the NYSE American Company Guide, citing the low selling price of its common stock.
- Appeal intended: According to the filing, the company "intends to request" a review by the Listings Qualifications Panel of the Committee for Review, though the filing notes "there can be no assurance that any such appeal will be successful."
- OTC transfer expected: The company's common stock was expected to begin trading on the OTC Pink Limited Market on November 11, 2026.
- SEC application pending: NYSE American stated it will apply to the SEC to delist the company's common stock pending completion of applicable procedures, including any appeal.
AtlasClear Holdings Receives NYSE American Delisting Notice on November 10, 2026
AtlasClear Holdings, Inc. (NYSE American:ATCH) disclosed in a Form 8-K filed November 12, 2026, that it received a notice from NYSE Regulation on November 10, 2026, informing the company that trading in its common stock had been suspended and that delisting proceedings had been initiated. According to the filing, NYSE American's determination was based on Section 1003(f)(v) of the NYSE American Company Guide, which pertains to the low selling price of the company's common stock.
The filing states that the company has the right to appeal the delisting determination to the Listings Qualifications Panel of the Committee for Review of the Board of Directors of NYSE American, and that it intends to exercise that right. However, the filing explicitly states "there can be no assurance that any such appeal will be successful." NYSE American indicated it will apply to the Securities and Exchange Commission to proceed with delisting, subject to the completion of applicable procedures and any appeal the company may file.
As a consequence of the trading suspension, the filing states the company's common stock was expected to begin trading on the OTC Pink Limited Market on November 11, 2026. A press release dated November 10, 2026, was attached as Exhibit 99.1 and incorporated by reference. The Form 8-K was signed by Sandip Patel, Chief Financial Officer and General Counsel of AtlasClear Holdings, Inc., on November 12, 2026. The filing notes that statements regarding the company's intention to regain compliance with listing requirements are forward-looking and subject to the company's cautionary language.
What Was Disclosed
AtlasClear Holdings reported that NYSE American suspended trading of its common stock and commenced delisting proceedings on November 10, 2026, citing low stock price under Section 1003(f)(v) of the NYSE American Company Guide. The company stated it intends to appeal the determination.



Please wait processing your request...